Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants

Condition:   Relapsing Remitting Multiple Sclerosis Intervention:   Drug: Natalizumab Sponsor:   Biogen Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials